FDA — authorised 25 June 1991
- Application: BLA019991
- Marketing authorisation holder: NOVO NORDISK INC
- Local brand name: NOVOLIN 70/30
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Novolin 70/30 on 25 June 1991
Yes. FDA authorised it on 25 June 1991.
NOVO NORDISK INC holds the US marketing authorisation.